as of 12/31/02 FORM 13F
Name of Reporting Manager: HAMBRECHT & QUIST CAPITAL MANAGEMENT LLC
Page 1 of 1
(SEC USE ONLY)
/
----------------------------------------------------------------------------------------------------------------------------------
ITEM 6:
ITEM 5: INVESTMENT DISCRETION
ITEM 1: ITEM 2: ITEM 3: ITEM 4: SHARES OF -------------------------
NAME OF ISSUER TITLE OF CLASS CUSIP FAIR MARKET PRINCIPAL (b) SHARED-
NUMBER VALUE AMOUNT (a) SOLE AS DEFINED (c) SHARED-
IN INSTR. V OTHER
----------------------------------------------------------------------------------------------------------------------------------
Abgenix Common 00039B107 $3,648,150 495,000 X
Adolor Common 00724X102 7,108,332 518,100 X
Aradigm Common 038505103 567,000 350,000 X
Biofield Common 090591207 228,505 878,866 X
Biofield (Restricted) Common 090591207 208,000 1,000,000 X
Biopure Common 09065H915 631,456 169,746 X
BioTransplant Common 09066Y107 320,633 712,518 X
Catalytica Energy Systems Common 148884109 354,701 128,515 X
Celgene Common 151020104 14,814,300 690,000 X
Corixa Common 21887F100 4,579,055 716,597 X
Cubist Pharmaceuticals Common 229990981 7,884,381 958,003 X
CV Therapeutics Common 126667104 9,953,713 546,307 X
Cytyc Common 232946103 4,429,717 434,286 X
deCODE Genetics Common 24386104 2,876,750 1,555,000 X
Digene Common 253752109 315,150 27,500 X
Dyax Common 26746E103 1,249,677 694,265 X
Endocardial Solutions Common 292962107 5,633,331 1,666,666 X
Endologix Common 292665106 280,500 330,000 X
Envirogen Common 294040100 15,416 20,833 X
EP MedSystems Common 26881P103 2,687,500 1,075,000 X
Exelixis Common 30161Q104 9,776,000 1,222,000 X
Genzyme Common 372917104 4,021,520 136,000 X
Gilead Sciences Common 37555B103 24,705,624 726,636 X
IDEXX Laboratories Common 45168D104 8,212,500 250,000 X
Impax Laboratories Common 45256B101 1,548,261 386,100 X
IVAX Common 465823102 6,603,572 544,400 X
Kosan Common 50064W107 2,667,765 439,500 X
Lexicon Genetics Common 5288872104 1,641,310 347,000 X
Lynx Therapeutics Common 551812308 813,850 1,985,000 X
Martek Biosciences Common 572901106 19,630,435 780,224 X
MedImmune Common 584699102 11,166,870 411,000 X
Molecular Devices Common 60851C107 4,788,949 290,768 X
Orthovita Common 68750U102 7,395,000 1,700,000 X
Quintiles Transnational Common 748767100 1,850,090 152,900 X
Rigel Pharmaceuticals Common 766559108 1,119,975 1,027,500 X
Telik Common 87959M109 7,773,313 666,665 X
Transkaryotic Therapies Common 893735100 3,787,245 382,550 X
Tularik Common 899165104 3,024,321 405,405 X
Versicor Common 925314106 7,519,993 696,941 X
Vertex Pharmaceuticals Common 92532F100 3,006,745 189,700 X
WebMD Common 94769M105 6,476,625 757,500 X
COLUMN TOTALS $205,316,230
-------------------------------------------------------------------------------------
Item 8:
Item 1: Item 7: Voting Authority (Shares)
Name of Issuer Managers --------------------------------
See Instr. V (a) Sole (b) Shared (c) None
-------------------------------------------------------------------------------------
Abgenix NA X
Adolor NA X
Aradigm NA X
Biofield NA X
Biofield (Restricted) NA X
Biopure NA X
BioTransplant NA X
Catalytica Energy Systems NA X
Celgene NA X
Corixa NA X
Cubist Pharmaceuticals NA X
CV Therapeutics NA X
Cytyc NA X
deCODE Genetics NA X
Digene NA X
Dyax NA X
Endocardial Solutions NA X
Endologix NA X
Envirogen NA X
EP MedSystems NA X
Exelixis NA X
Genzyme NA X
Gilead Sciences NA X
IDEXX Laboratories NA X
Impax Laboratories NA X
IVAX NA X
Kosan NA X
Lexicon Genetics NA X
Lynx Therapeutics NA X
Martek Biosciences NA X
MedImmune NA X
Molecular Devices NA X
Orthovita NA X
Quintiles Transnational NA X
Rigel Pharmaceuticals NA X
Telik NA X
Transkaryotic Therapies NA X
Tularik NA X
Versicor NA X
Vertex Pharmaceuticals NA X
WebMD NA X
COLUMN TOTALS